1. Home
  2. IMAX vs OGN Comparison

IMAX vs OGN Comparison

Compare IMAX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$40.68

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.63

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
OGN
Founded
1967
1923
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
IMAX
OGN
Price
$40.68
$6.63
Analyst Decision
Strong Buy
Hold
Analyst Count
9
4
Target Price
$44.44
$11.75
AVG Volume (30 Days)
987.0K
4.1M
Earning Date
06-01-2026
05-14-2026
Dividend Yield
N/A
1.19%
EPS Growth
31.25
N/A
EPS
0.63
0.72
Revenue
$410,212,000.00
$6,216,000,000.00
Revenue This Year
$9.80
$0.42
Revenue Next Year
$7.11
$1.67
P/E Ratio
$64.39
$9.35
Revenue Growth
16.47
N/A
52 Week Low
$20.48
$6.18
52 Week High
$43.16
$15.88

Technical Indicators

Market Signals
Indicator
IMAX
OGN
Relative Strength Index (RSI) 61.80 32.93
Support Level $35.94 $6.34
Resistance Level $43.16 $7.87
Average True Range (ATR) 1.68 0.30
MACD 0.27 -0.10
Stochastic Oscillator 66.11 4.39

Price Performance

Historical Comparison
IMAX
OGN

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: